QA: LIXTE BIOTECHNOLOGY HOLDINGS INC. in us_pharma/2016

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001335105_2017_LIXTE_BIOTECHNOLOGY_HOLDINGS_INC.pdf

Logs

warning Missing logo subcommand.report {}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0001335105')"}

Graph

Absolute values for 0001335105, LIXTE BIOTECHNOLOGY HOLDINGS INC.

  xvar xval
0 AssetsCurrent 433,411
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 0
4 LiabilitiesCurrent 218,651
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 833,782
9 ResearchAndDevelopmentExpense 1,301,133
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome 183
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 433,411
1 Liabilities 218,651
2 Expenses 2,134,915
3 Revenues 0
4 StockholdersEquity 214,760
5 NetIncome -2,134,732
6 ComprehensiveNetIncome -2,134,732
7 BaseVar 1,393,580
8 EconomicCapitalRatio -5.41

Edgar->Model Mapping

Feature Distribution